Drug Information Analysis Service

Grossman MI Kurata JH Rotter JI , Peptic ulcers: New treatment, new diseases. Ann Intern Med 1981; 95: 609–26.

Wetterhus S Aubert E Berg CE , The effect of trimipramine (Surmontil) on symptoms and healing of peptic ulcer. A double blind study. Scand J Gastroenterol 1977; 12 (suppl 43): 33–8.

Miglioli M Corinaldesi R Rossi N Galassi G Difebo G Barbara L. Controlled comparison of cimetidine and trimipramine in duodenal ulcer. Curr Ther Res 1982; 31: 7–13.

Becker U Faurschou P Jensen J Beckpedersen P Ranlou PJ . Efficacy of trimipramine and cimetidine in treatment of duodenal ulcer. Scand J Gastroenterol 1983; 18: 137–43.

Nitter L Haraldsson A Hoick P , The effect of trimipramine on the healing of peptic ulcer. Scand J Gastroenterol 1977; 12 (suppl 43): 39–40.

Mangla JC Pereir M. Tricyclic antidepressants in the treatment of peptic ulcer disease. Arch Intern Med 1982; 142: 273–5.

Rudd TE Hoff GS Tonder M Holter O. Doxepin and cimetidine in the treatment of duodenal ulcer: An open clinical and endoscopic study. J Clin Psychiatry 1982; 43: 56–8.

Richelson E. Tricyclic antidepressants, drugs for other diseases. Arch Intern Med 1982; 142: 231–2.

Green JP Maayani S. Tricyclic antidepressant drugs block histamine H₂ receptor in brain. Nature 1977; 269: 163–5.

Bohman T Schrumpf E Myren J. The effect of trimipramine (Surmontil) on gastric secretion and the serum gastrin release in healthy young students. Scand J Gastroenterol 1977; 12 (suppl 43): 7–17.

Roland M Berstad A Myren J Liavag I. Effect of trimipramine (Surmontil) on gastric secretion of acid and pepsin in man. Scand J Gastroenterol 1977; 12 (suppl 43): 19–25.

Myren J Berstad A. The early effect of trimipramine (Surmontil) on gastric secretion in man. Scand J Gastroenterol 1975; 10: 817–9.

Degrenaucourt J. Protection by trimipramine against gastric mucosal barrier dysfunction induced by ethanol in rats (abstract). Gastroenterology 1977; 76: 1119.

Glassman A Bigger J. Cardiovascular effects of therapeutic doses of tricyclic antidepressants. Arch Gen Psychiatry 1981; 38: 815–20.

Vohra J Burrows G Hunt D Sloman G. The effect of toxic and therapeutic doses of tricyclic antidepressant drugs on intracardiac conduction. Eur J Cardiol 1975; 3–3: 214–27.

Fregley JD . Herpes zoster, a challenge in management. Prim Care 1981; 8: 715–31.

Bay CG . Chickenpox (varicella) and herpes zoster. In: Isselbacher KJ Adams RD Braunwald E Petersdorf RG Wilson JD , eds. Harrison's principles of internal medicine. 9th ed. New York: McGraw Hill, 1980: 801–4.

Keczkes K Basher AM . Do corticosteroids prevent postherpetic neuralgia? Br Med J 1981; 102: 551–5.

Hatangdi VS Boas RA Richards EG . Postherpetic neuralgia-management with antiepileptics and tricyclic drugs. Adv Pain Res Ther 1976; 1: 583–7.

Rafferty H. The management of postherpetic pain using sodium valproate and amitriptyline. J Irish Med Assoc 1979; 72: 399–401.

Watson CP Evans RJ Reed K Merskey H Goldsmith L Warsh J. Amitriptyline versus placebo in postherpetic neuralgia. Neurology 1982; 32: 671–3.

Eaglestein WH Katz R Brown JA . The effects of early corticosteroid therapy on the skin eruptions and pain of herpes zoster. JAMA 1970; 211: 1681–3.

Kernbaum S Hauchecorne J. Administration of levodopa for relief of herpes zoster pain. JAMA 1981; 246: 132–4.

Hernandez-Perez E. Dihydroemetine therapy for herpes zoster, a comparison with corticosteroids. Cutis 1980; 25: 424–6.

Killian JM Fromm GH . Carbamazepine in the treatment of neuralgia. Arch Neurol 1968; 19: 129–36.

Epstein E. Treatment of herpes zoster and postzoster neuralgia by subcutaneous injection of triamcinolone. Int J Dermatol 1981; 20: 65–8.

Spiro AH Peppercorn MA . Evaluation and medical therapy for acute gastrointestinal bleeding. Pharmacotherapy 1982; 2: 235–41.

Gusberg RJ . Shunts for variceal hemorrhage: Why? when? what? Surg Clin North Am 1980; 60: 1265–72.

Sax FL Cooperman AM . Bleeding esophageal varices. Surg Clin North Am 1981; 61: 209–19.

Iber FL . Management of the patient with esophageal varices. Mod Treat 1970; 7: 1320–31.

Lebrec D Corbic M Nouel O Benhamou JP . Propranolol—a medical treatment for portal hypertension? Lancet 1980; 2: 180–2.

Fleishman S. Propranolol to lower portal venous pressure. Lancet 1981; 1: 382–3.

Lebrec D Bernuau J Rueff B Nouel O Bouygues M Benhamou JP . Propranolol in prevention of recurrent gastrointestinal bleeding in cirrhotic patients. Lancet 1981; 1: 920–1.

Lebrec D Poynard T Hillon P Benhamou JP . Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis. N Engl J Med 1981; 305: 1371–4.

Sogaard PE . Propranolol in portal hypertension Getter). Lancet 1981; 1: 1204.

Bleichner G Parent A Raffray Y Squara P. Traitment des hemorragies dues a l'hypertension portale par le propranolol. Nouv Presse Med 1981; 10: 1072–3.

Lebrec C Bernuau J Rueff B Benhamou JP . Gastrointestinal bleeding after abrupt cessation of propranolol administration in cirrhosis (letter). N Engl J Med 1982; 307: 560.

Marighini A Simonetti RM Marceno MP Pagliaro L. Propranolol for gastrointestinal bleeding in cirrhosis (letter). N Engl J Med 1982; 307: 1710.

Colman JC Jennings GL McLean AJ Mignot PR Dudley FJ . Propranolol in decompensated alcoholic cirrhosis. Lancet 1982; 2: 1040–1.

Burroughs AK Jenkins WJ Sherlock S , Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med 1983; 309: 1539–42.